Concepedia
Statistics
Publications
60
Citations
2.9K
H-Index
27
Active since
1996
Affiliations
University of Kansas(Current)
Pearl River Community College
Shanghai Jiao Tong University
Ruijin Hospital
Pfizer (United States)
Yongbo Hu is an author at University of Kansas specializing in medicinal chemistry, life sciences, and pharmacology.
Publications per year
1996–2025
Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy
Jason B. Cross, David C. Thompson, Junaid Baber et al. · Journal of Chemical Information and Modeling · 2009 · 455 citations
Pharmacy, Bioinformatics, Medicinal Chemistry +17
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer
Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 208 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +11
Mobocertinib (TAK-788): A Targeted Inhibitor of <i>EGFR</i> Exon 20 Insertion Mutants in Non–Small Cell Lung Cancer
Francois Gonzalvez, Sylvie Vincent, Theresa E. Baker et al. · Cancer Discovery · 2021 · 195 citations · Full text
Medicine, Oncology, Pharmacology +15
miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
Yongbo Hu, Yongfang Zhang, Hao Wang et al. · Cell Death and Disease · 2019 · 119 citations · Full text
Life Sciences, Neurobiology, Neuroscience +17
LncRNA-SNHG1 contributes to gastric cancer cell proliferation by regulating DNMT1
Yongbo Hu, Zhen Ma, Yiming He et al. · Biochemical and Biophysical Research Communications · 2017 · 112 citations
Medicine, Molecular Biology, Molecular Genetics +12
1–5 of 60